Identification of Fibrotic Biomarkers Associated with Macrophages in Diabetic Nephropathy
Medical Science Monitor · 2023
DOI: 10.12659/msm.940847 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Science Monitor, 2023. Verfasst von Rongrong Hou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China (mainland). Hauptthemen laut MEDLINE: Diabetic Nephropathies, Diabetes Mellitus. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China (mainland).
- Department of Endocrinology, Xi'an International Medical Center Hospital, Xi'an, Shaanxi, China (mainland).
- Department of Cardiology, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, China (mainland).
Zitieren
APA
Hou, R., Gao, L., Long, J., Cao, J., Yin, T., & Xu, J. (2023). Identification of Fibrotic Biomarkers Associated with Macrophages in Diabetic Nephropathy. Medical Science Monitor. https://doi.org/10.12659/msm.940847
Vancouver
Hou R, Gao L, Long J, Cao J, Yin T, Xu J. Identification of Fibrotic Biomarkers Associated with Macrophages in Diabetic Nephropathy. Medical Science Monitor. 2023. doi:10.12659/msm.940847
BibTeX
@article{Hou2023,
author = {Hou, Rongrong and Gao, Lei and Long, Junhong and Cao, Jin and Yin, Tao and Xu, Jing},
title = {Identification of Fibrotic Biomarkers Associated with Macrophages in Diabetic Nephropathy},
journal = {Medical Science Monitor},
year = {2023},
doi = {10.12659/msm.940847}
}
EUVIMED